Compare EHang Holdings Ltd - ADR (EH) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
EHang Holdings Ltd - ADR vs Tenet Healthcare Corporation — how do they compare? EHang Holdings Ltd - ADR trades at $5.37 (market cap $414.87M), while Tenet Healthcare Corporation trades at $198.69 (market cap $16.57B). The key difference: Tenet Healthcare Corporation is far larger — about 39.9× EHang Holdings Ltd - ADR's market cap, and Tenet Healthcare Corporation is trading nearer its 52-week high, EHang Holdings Ltd - ADR nearer its low. Which is the better fit depends on your goals.
| EH | THC | |
|---|---|---|
Market Cap | $414.87M | $16.57B |
Sector | Industrials | Health |
52-Week High | $19.99 | $244.80 |
52-Week Low | $5.41 | $148.38 |
Enterprise Value | $354.54M | $26.81B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EHang Holdings (EH) trades at $5.41, down 0.73% on the day, with technical indicators showing bearish momentum and mixed sentiment. The company reported Q1 2026 revenue of $418 million, flat year-over-year but sharply lower than the prior quarter due to delivery timing. Despite a strong gross margin of 61.53%, the company continues to post significant net losses (-$276 million in 2025) with negative ROE and ROA. Recent news highlights both operational progress in eVTOL certification and a $30 million share repurchase program announced in June 2026.
The outlook remains challenging with persistent losses and high cash burn, though analyst consensus suggests modest upside to the $6.97 price target. Key risks include execution on commercialization, competitive pressures in the air mobility sector, and reliance on financing activities to fund operations. The stock presents speculative appeal for investors betting on long-term eVTOL adoption, but requires careful risk management given the current financial profile.
Tenet Healthcare (THC) trades at $198.46, up 8.04% in the last 24 hours, showing strong momentum. The stock is supported by a bullish analyst consensus with a $235.88 price target, while recent earnings have consistently beaten expectations. However, technical indicators signal a bearish short-term trend, with the price currently testing key support levels near $191.
The outlook is positive based on solid fundamentals, including a low P/E of 10 and strong profitability metrics like a 37.87% ROE. Key risks include market volatility ahead of Q2 2026 earnings on July 24 and potential macroeconomic pressures on the healthcare sector. The primary opportunity lies in the stock's attractive valuation relative to its growth and analyst targets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About EHang Holdings Ltd - ADR
EHang Holdings Ltd is an autonomous aerial vehicle (AAV) technology platform company. It focuses on making safe, autonomous and eco-friendly air mobility accessible to everyone. EHang provides customers in various industries with AAV products and commercial solutions: air mobility (including passenger transportation and logistics), smart city management and aerial media solutions. As the forerunner of cutting-edge AAV technologies and commercial solutions in the global Urban Air Mobility industry, it continues to explore the boundaries of the sky to make flying technologies benefit life in smart cities.
Read more on EH →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
